Skip to content

MIRM

Mirum Pharmaceuticals, Inc.

Stock

$82.93−0.99 (−1.18%)Close Oct 2, 2026

Adjusted price

+15.58% total return, past year

Key statistics

Market cap
$5.4B
P/E (TTM)
—
52-week range
$64.10$128.57
Beta (5Y monthly)
0.61
Median dollar volume
$64.2M
Shares outstanding
64.9M
Revenue, last 12 months
$618M
Sector
Health Care
First close
Jul 18, 2019

Total

1M
−16.9%
YTD
+5.0%
1Y
+15.6%

Per year

3Y
+41.5%
5Y
+33.8%
Since 2019
+29.0%

Financials

Revenue

$618MLast 12 months

Operating income

−$834MLast 12 months

Net income

−$860MLast 12 months

EPS

−$14.57Last 12 months

Free cash flow

−$229MLast 12 months

Annual returns

2019 from Jul 18 · 2026 through Oct 2